Cited 18 times in
Mortality Risk Factors for Patients with Septic Shock after Implementation of the Surviving Sepsis Campaign Bundles
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 구남수 | - |
dc.contributor.author | 김용찬 | - |
dc.contributor.author | 김은진 | - |
dc.contributor.author | 김준명 | - |
dc.contributor.author | 오동현 | - |
dc.contributor.author | 정수진 | - |
dc.contributor.author | 정우용 | - |
dc.contributor.author | 정인영 | - |
dc.contributor.author | 최준용 | - |
dc.date.accessioned | 2017-10-26T08:10:46Z | - |
dc.date.available | 2017-10-26T08:10:46Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/153077 | - |
dc.description.abstract | BACKGROUND: Septic shock remains a leading cause of death, despite advances in critical care management. The Surviving Sepsis Campaign (SSC) has reduced morbidity and mortality. This study evaluated risk factors for mortality in patients with septic shock who received treatment following the SSC bundles. MATERIALS AND METHODS: This retrospective cohort study included patients with septic shock who received treatments following SSC bundles in an urban emergency department between November 2007 and November 2011. Primary and secondary endpoints were all-cause 7- and 28-day mortality. RESULTS: Among 436 patients, 7- and 28-day mortality rates were 7.11% (31/436) and 14% (61/436), respectively. In multivariate analysis, high lactate level (odds ratio [OR], 1.286; 95% confidence interval [CI], 1.016-1.627; P=0.036) and low estimated glomerular filtration rate (OR, 0.953; 95% CI, 0.913-0.996; P=0.032) were independent risk factors for 7-day mortality. Risk factors for 28-day mortality were high lactate level (OR, 1.346; 95% CI, 1.083-1.673; P=0.008) and high Acute Physiology and Chronic Health Evaluation II score (OR, 1.153; 95% CI, 1.029-1.293; P=0.014). CONCLUSION: The risk of mortality of septic shock patients remains high in patients with high lactate levels and acute kidney injury. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | Korean, English | - |
dc.publisher | 대한감염학회 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Mortality Risk Factors for Patients with Septic Shock after Implementation of the Surviving Sepsis Campaign Bundles | - |
dc.type | Article | - |
dc.publisher.location | Korea | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Internal Medicine | - |
dc.contributor.googleauthor | Je Eun Song | - |
dc.contributor.googleauthor | Moo Hyun Kim | - |
dc.contributor.googleauthor | Woo Yong Jeong | - |
dc.contributor.googleauthor | In Young Jung | - |
dc.contributor.googleauthor | Dong Hyun Oh | - |
dc.contributor.googleauthor | Yong Chan Kim | - |
dc.contributor.googleauthor | Eun Jin Kim | - |
dc.contributor.googleauthor | Su Jin Jeong | - |
dc.contributor.googleauthor | Nam Su Ku | - |
dc.contributor.googleauthor | June Myung Kim | - |
dc.contributor.googleauthor | Jun Yong Choi | - |
dc.identifier.doi | 10.3947/ic.2016.48.3.199 | - |
dc.contributor.localId | A00752 | - |
dc.contributor.localId | A00823 | - |
dc.contributor.localId | A00953 | - |
dc.contributor.localId | A02059 | - |
dc.contributor.localId | A02361 | - |
dc.contributor.localId | A03638 | - |
dc.contributor.localId | A04670 | - |
dc.contributor.localId | A03695 | - |
dc.contributor.localId | A04191 | - |
dc.contributor.localId | A00189 | - |
dc.relation.journalcode | J01053 | - |
dc.identifier.eissn | 2092-6448 | - |
dc.relation.journalsince | 2011~ | - |
dc.identifier.pmid | 27659434 | - |
dc.relation.journalbefore | ~2010 감염과 화학요법 | - |
dc.subject.keyword | Mortality | - |
dc.subject.keyword | Risk factors | - |
dc.subject.keyword | Septic shock | - |
dc.contributor.alternativeName | Ku, Nam Su | - |
dc.contributor.alternativeName | Kim, Yong Chan | - |
dc.contributor.alternativeName | Kim, Eun Jin | - |
dc.contributor.alternativeName | Kim, June Myung | - |
dc.contributor.alternativeName | Oh, Dong Hyun | - |
dc.contributor.alternativeName | Jeong, Su Jin | - |
dc.contributor.alternativeName | Jeong, Wooyong | - |
dc.contributor.alternativeName | Jung, In Young | - |
dc.contributor.alternativeName | Choi, Jun Yong | - |
dc.contributor.affiliatedAuthor | Kim, Yong Chan | - |
dc.contributor.affiliatedAuthor | Kim, Eun Jin | - |
dc.contributor.affiliatedAuthor | Kim, June Myung | - |
dc.contributor.affiliatedAuthor | Oh, Dong Hyun | - |
dc.contributor.affiliatedAuthor | Jeong, Su Jin | - |
dc.contributor.affiliatedAuthor | Jeong, Wooyong | - |
dc.contributor.affiliatedAuthor | Jung, In Young | - |
dc.contributor.affiliatedAuthor | Choi, Jun Yong | - |
dc.contributor.affiliatedAuthor | Ku, Nam Su | - |
dc.citation.volume | 48 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 199 | - |
dc.citation.endPage | 208 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, Vol.48(3) : 199-208, 2016 | - |
dc.date.modified | 2017-10-24 | - |
dc.identifier.rimsid | 41081 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.